Hypothermic Oxygenated Perfusion of Liver Grafts Donated after Circulatory Death in Liver Transplantation - A Phase 1 Clinical Trial
Completed
- Conditions
- Patients with endstage liver disease who undergo liver transplantation with a graft from donation after circulatory death (DCD) donorDutch: Patiënten met eindstadium leverfalen die een lever transplantatie ondergaan met een lever afkomstig van een donor overleden na circulatiestilstand
- Registration Number
- NL-OMON19926
- Lead Sponsor
- niversity Medical Center GroningenHanzeplein 1P.O. Box 30.0019700 RB GroningenThe Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
Adult patients (> 18 years old) awaiting a liver transplantation and who have been allocated a liver graft from a DCD (Maastricht type 3) donor with a body weight of > 40 kg
Exclusion Criteria
Patients with mental conditions rendering then incapable to understand the nature, scope and consequences of the trial; listed as high urgency; positive test for HIV; pregnant or nursing; donor positive for hepatitis B or C; expected cold ischemia time of > 8 hours
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint of this trial will be graft survival within six months after DCD liver transplantation.
- Secondary Outcome Measures
Name Time Method